Quantitative Imaging Biomarkers for Risk Stratification of Patients with Recurrent Glioblastoma Treated with Bevacizumab.

Quantitative Imaging Biomarkers for Risk Stratification of Patients with Recurrent Glioblastoma Treated with Bevacizumab.

Item
http://www.wikidata.org/entity/Q38789124
Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.Defining the biological basis of radiomic phenotypes in lung cancer.Multiparametric MRI and [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging Is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma.Radiomics and radiogenomics for precision radiotherapy.Radiomic subtyping improves disease stratification beyond key molecular, clinical and standard imaging characteristics in patients with glioblastoma.Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.Imaging in neuro-oncology.
P2860

Quantitative Imaging Biomarkers for Risk Stratification of Patients with Recurrent Glioblastoma Treated with Bevacizumab.

Item
http://www.wikidata.org/entity/Q38789124
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Quantitative Imaging Biomarker ...... toma Treated with Bevacizumab.
@en
type
label
Quantitative Imaging Biomarker ...... toma Treated with Bevacizumab.
@en
prefLabel
Quantitative Imaging Biomarker ...... toma Treated with Bevacizumab.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Quantitative Imaging Biomarker ...... toma Treated with Bevacizumab.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932